# Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).

> **NCT05868525** · PHASE4 · RECRUITING · sponsor: **Loma Linda University** · enrollment: 98 (estimated)

## Conditions studied

- Blunt Cerebrovascular Injury

## Interventions

- **DRUG:** Aspirin 325Mg Tab, Aspirin 81Mg Tab

## Key facts

- **NCT ID:** NCT05868525
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-23
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05868525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05868525, "Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05868525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*